Biostatistics Seminar Series

Biostatistics at the FDA - Jessica (Jeongsook) Kim, FDA

Thursday 9/20 3:30PM - 4:30PM
Public Health Auditorium (G23)

Biostatistics at FDA

“The Office of Biostatistics in Center for Drugs Evaluation and Research (CDER) at the Food and Drug Administration (FDA) is recognized for excellence in the application and communication of statistical science in drug regulation and development.  We play a central role in promoting innovative, science-based, quantitative decision-making throughout the drug development life-cycle.  To achieve this vision, we provide CDER with statistical leadership, expertise, and advice to ensure that safe and effective drugs are available to the American people.  (Mission of Office of Biostatistics)”

An overview of the FDA statisticians’ work will be provided with the aims of creating interest among graduate students in working at FDA and informing professors of opportunities to work with us. I will present a general work of our Office of Biostatistics at the FDA with some highlights of the work of statistical reviewer followed by an informal meeting with graduate students.


Last Updated On Friday, September 7, 2018 by Tang, Lu
Created On Friday, August 24, 2018